OCULAR SCIENCES INC /DE/·4

Jan 10, 5:36 PM ET

POTTER MARY JO 4

4 · OCULAR SCIENCES INC /DE/ · Filed Jan 10, 2005

Insider Transaction Report

Form 4
Period: 2005-01-06
Transactions
  • Disposition to Issuer

    Director Stock Option (right to buy)

    2005-01-06$27.72/sh10,000$277,2000 total
    Exercise: $44.79Exp: 2014-08-02Common Stock (10,000 underlying)
  • Disposition to Issuer

    Director Stock Option (right to buy)

    2005-01-06$52.01/sh30,000$1,560,3000 total
    Exercise: $20.50Exp: 2013-07-28Common Stock (30,000 underlying)
Footnotes (3)
  • [F1]Pursuant to the Merger Agreement among The Cooper Companies, Inc. ("Cooper"), TCC Acquisition Corp. and issuer ("Merger Agreement"), this option, which provided for vesting at the rate of 2.78% a month on the last day of each month beginning August 31, 2003 was accelerated and canceled in exchange for $390,083.58 and 6,877 shares of Cooper common stock, having a market value of $72.51 per share.
  • [F2]Pursuant to the Merger Agreement, this option, which provided for vesting at the rate of 2.78% a month on the last day of each month beginning September 30, 2004, was accelerated and canceled in exchange for $23,421.85 and 412 shares of Cooper common stock, having a market value of $72.51 per share.
  • [F3]This combination of cash and Cooper common stock represents the per share value of the merger consideration ($72.51 per share) minus the exercise price of the option, multiplied by the number of shares of issuer common stock subject to such option.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -